Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...

Here is how AngioDynamics (ANGO) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.

Is AngioDynamics (ANGO) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. AngioDynamics is a member of the Medical sector. This group ...

AngioDynamics (ANGO) closed the last trading session at $9.11, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

H.C. Wainwright raised the firm’s price target on AngioDynamics (ANGO) to $16 from $15 and keeps a Buy rating on the shares. The company ...

— We have everything you need: full data on over 800 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & ...

Good morning and welcome to the AngioDynamics fiscal year 20,253 quarter earnings call. (Operator Instructions) As a reminder, this conference call is being recorded. The news released detailing ...

AngioDynamics Inc. reported its fiscal second-quarter 2025 earnings, surpassing expectations with an earnings per share (EPS) of $0.03 against a forecast of -$0.11. The company also reported revenue ...